| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Microcirculation Research Institute and Department of Medical Physiology, Texas A&M University Health Science Center, College Station, Texas 77843-1114; and 2 Department of Pharmacology, University of Florence, 50134 Florence, Italy
Vascular endothelial growth factor (VEGF) is an endothelium-specific secreted protein that potently stimulates vasodilation, microvascular hyperpermeability, and angiogenesis. Nitric oxide (NO) is also reported to modulate vascular tone, permeability, and capillary growth. Therefore, we hypothesized that VEGF might regulate endothelial production of NO. The production of nitrogen oxides by human umbilical vein endothelial cells (HUVECs) was measured after 1, 12, 24, and 48 h of incubation with VEGF. VEGF treatment resulted in both an acute (1 h) and chronic (>24 h) stimulation of NO production. Furthermore, Western and Northern blotting revealed a VEGF-elicited, dose-dependent increase in the cellular content of endothelial cell nitric oxide synthase (ecNOS) message and protein that may account for the chronic upregulation of NO production elicited by VEGF. Finally, endothelial cells pretreated with VEGF for 24 h and subsequently exposed to A-23187 for 1 h produced NO at approximately twice the rate of cells that were not pretreated with VEGF. We conclude that VEGF upregulates ecNOS enzyme and elicits a biphasic stimulation of endothelial NO production.
nitric oxide; vascular endothelial growth factor; endothelial cell; nitric oxide synthase; human umbilical vein endothelial cells
This article has been cited by other articles:
|
|
 |
|
  P. Bhargava VEGF kinase inhibitors: how do they cause hypertension? Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2009; 297(1): R1 - R5. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ma and D. J. Waxman Combination of antiangiogenesis with chemotherapy for more effective cancer treatment Mol. Cancer Ther., December 1, 2008; 7(12): 3670 - 3684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Benest, O. A. Stone, W. H. Miller, C. P. Glover, J. B. Uney, A. H. Baker, S. J. Harper, and D. O. Bates Arteriolar Genesis and Angiogenesis Induced by Endothelial Nitric Oxide Synthase Overexpression Results in a Mature Vasculature Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1462 - 1468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Kunig, V. Balasubramaniam, N. E. Markham, G. Seedorf, J. Gien, and S. H. Abman Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L1068 - L1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Yuan New insights into eNOS signaling in microvascular permeability Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1029 - H1031. [Full Text] [PDF]
|
|
|
|
|
|
N. Huang, A. Khan, H. Ashrafpour, P. C. Neligan, C. R. Forrest, C. D. Kontos, and C. Y. Pang Efficacy and mechanism of adenovirus-mediated VEGF-165 gene therapy for augmentation of skin flap viability Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H127 - H137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. T. Jackson and R. C. Venema Quercetin Inhibits eNOS, Microtubule Polymerization, and Mitotic Progression in Bovine Aortic Endothelial Cells J. Nutr., May 1, 2006; 136(5): 1178 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Kunig, V. Balasubramaniam, N. E. Markham, D. Morgan, G. Montgomery, T. R. Grover, and S. H. Abman Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L529 - L535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Milkiewicz, O. Hudlicka, M. D. Brown, and H. Silgram Nitric oxide, VEGF, and VEGFR-2: interactions in activity-induced angiogenesis in rat skeletal muscle Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H336 - H343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kobayashi, K. Taguchi, T. Yasuhiro, T. Matsumoto, and K. Kamata Impairment of PI3-K/Akt Pathway Underlies Attenuated Endothelial Function in Aorta of Type 2 Diabetic Mouse Model Hypertension, December 1, 2004; 44(6): 956 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Khan, H. Ashrafpour, N. Huang, P. C. Neligan, C. Kontos, A. Zhong, C. R. Forrest, and C. Y. Pang Acute local subcutaneous VEGF165 injection for augmentation of skin flap viability: efficacy and mechanism Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1219 - R1229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Aramoto, J. W. Breslin, P. J. Pappas, R. W. Hobson II, and W. N. Duran Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1590 - H1598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-R. Tang, N. E. Markham, Y.-J. Lin, I. F. McMurtry, A. Maxey, J. P. Kinsella, and S. H. Abman Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor Am J Physiol Lung Cell Mol Physiol, August 1, 2004; 287(2): L344 - L351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kobayashi, T. Matsumoto, K. Ooishi, and K. Kamata Differential expression of {alpha}2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H135 - H148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. V. Dantas, J. Igarashi, and T. Michel Sphingosine 1-phosphate and control of vascular tone Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2045 - H2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Lloyd, B. M. Prior, H. T. Yang, and R. L. Terjung Angiogenic growth factor expression in rat skeletal muscle in response to exercise training Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1668 - H1678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kobayashi and K. Kamata Short-term insulin treatment and aortic expressions of IGF-1 receptor and VEGF mRNA in diabetic rats Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1761 - H1768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. S. Katusic Therapeutic Angiogenesis: New Indication for Endothelial NO Synthase Gene Transfer Arterioscler Thromb Vasc Biol, August 1, 2002; 22(8): 1254 - 1255. [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Cooke and D. W. Losordo Nitric Oxide and Angiogenesis Circulation, May 7, 2002; 105(18): 2133 - 2135. [Full Text] [PDF]
|
|
|
|
 |
|
 O. Devuyst New insights in the molecular mechanisms regulating peritoneal permeability Nephrol. Dial. Transplant., April 1, 2002; 17(4): 548 - 551. [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Kuenen, L. Rosen, E. F. Smit, M. R.N. Parson, M. Levi, R. Ruijter, H. Huisman, M. A. Kedde, P. Noordhuis, W. J.F. van der Vijgh, et al. Dose-Finding and Pharmacokinetic Study of Cisplatin, Gemcitabine, and SU5416 in Patients With Solid Tumors J. Clin. Oncol., March 15, 2002; 20(6): 1657 - 1667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Schnyder, M. Pittet, J. Durand, and S. Schnyder-Candrian Rapid effects of glucose on the insulin signaling of endothelial NO generation and epithelial Na transport Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E87 - E94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Wothe, A. Hohimer, M. Morton, K. Thornburg, G. Giraud, and L. Davis Increased coronary blood flow signals growth of coronary resistance vessels in near-term ovine fetuses Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R295 - R302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Marchand, N. Noiseux, J.-F. Tanguay, and M. G. Sirois Blockade of in vivo VEGF-mediated angiogenesis by antisense gene therapy: role of Flk-1 and Flt-1 receptors Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H194 - H204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Bridges, M. S. Ola, P. D. Prasad, A. El-Sherbeny, V. Ganapathy, and S. B. Smith Regulation of taurine transporter expression by NO in cultured human retinal pigment epithelial cells Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1825 - C1836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Lloyd, H. T. Yang, and R. L. Terjung Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2528 - H2538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I.M. Campbell, Y. Zhao, R. Sandhu, and D. J. Stewart Cell-Based Gene Transfer of Vascular Endothelial Growth Factor Attenuates Monocrotaline-Induced Pulmonary Hypertension Circulation, October 30, 2001; 104(18): 2242 - 2248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Griffin, C. R. Woodman, E. M. Price, M. H. Laughlin, and J. L. Parker Endothelium-Mediated Relaxation of Porcine Collateral-Dependent Arterioles Is Improved by Exercise Training Circulation, September 18, 2001; 104(12): 1393 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rajagopalan, M. Shah, A. Luciano, R. Crystal, and E. G. Nabel Adenovirus-Mediated Gene Transfer of VEGF121 Improves Lower-Extremity Endothelial Function and Flow Reserve Circulation, August 14, 2001; 104(7): 753 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Marinos, W. Zhang, G. Wu, K. A. Kelly, and C. J. Meininger Tetrahydrobiopterin levels regulate endothelial cell proliferation Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H482 - H489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Zachary Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1375 - C1386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. D. VRIESE, R. G. TILTON, M. ELGER, C. C. STEPHAN, W. KRIZ, and N. H. LAMEIRE Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes J. Am. Soc. Nephrol., May 1, 2001; 12(5): 993 - 1000. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Fukumura, T. Gohongi, A. Kadambi, Y. Izumi, J. Ang, C.-O. Yun, D. G. Buerk, P. L. Huang, and R. K. Jain Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability PNAS, February 27, 2001; 98(5): 2604 - 2609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Saijonmaa, T. Nyman, R. Kosonen, and F. Fyhrquist Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H885 - H891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Partovian, S. Adnot, B. Raffestin, V. Louzier, M. Levame, I. M. Mavier, P. Lemarchand, and S. Eddahibi Adenovirus-Mediated Lung Vascular Endothelial Growth Factor Overexpression Protects against Hypoxic Pulmonary Hypertension in Rats Am. J. Respir. Cell Mol. Biol., December 1, 2000; 23(6): 762 - 771. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Lakshminarayanan, D. A. Antonetti, T. W. Gardner, and J. M. Tarbell Effect of VEGF on Retinal Microvascular Endothelial Hydraulic Conductivity: The Role of NO Invest. Ophthalmol. Vis. Sci., December 1, 2000; 41(13): 4256 - 4261. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Kamada, M. Nakatsuka, K. Asagiri, S. Noguchi, T. Habara, M. Takata, and T. Kudo GnRH agonist-suppressed expression of nitric oxide synthases and generation of peroxynitrite in adenomyosis Hum. Reprod., December 1, 2000; 15(12): 2512 - 2519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Brekken, J. P. Overholser, V. A. Stastny, J. Waltenberger, J. D. Minna, and P. E. Thorpe Selective Inhibition of Vascular Endothelial Growth Factor (VEGF) Receptor 2 (KDR/Flk-1) Activity by a Monoclonal Anti-VEGF Antibody Blocks Tumor Growth in Mice Cancer Res., September 1, 2000; 60(18): 5117 - 5124. [Abstract] [Full Text]
|
|
|
|
|
|
A. Vadapalli, R. N. Pittman, and A. S. Popel Estimating oxygen transport resistance of the microvascular wall Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H657 - H671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Zachary, A. Mathur, S. Yla-Herttuala, and J. Martin Vascular Protection : A Novel Nonangiogenic Cardiovascular Role for Vascular Endothelial Growth Factor Arterioscler Thromb Vasc Biol, June 1, 2000; 20(6): 1512 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rousseau, F. Houle, H. Kotanides, L. Witte, J. Waltenberger, J. Landry, and J. Huot Vascular Endothelial Growth Factor (VEGF)-driven Actin-based Motility Is Mediated by VEGFR2 and Requires Concerted Activation of Stress-activated Protein Kinase 2 (SAPK2/p38) and Geldanamycin-sensitive Phosphorylation of Focal Adhesion Kinase J. Biol. Chem., March 31, 2000; 275(14): 10661 - 10672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-Q. Shen, D. Y. Lee, and T. F. Zioncheck Vascular Endothelial Growth Factor Governs Endothelial Nitric-oxide Synthase Expression via a KDR/Flk-1 Receptor and a Protein Kinase C Signaling Pathway J. Biol. Chem., November 12, 1999; 274(46): 33057 - 33063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Cohen, J. M. Carbajal, and R. C. Schaeffer Jr. VEGF stimulates tyrosine phosphorylation of beta -catenin and small-pore endothelial barrier dysfunction Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H2038 - H2049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Lee, A. N. Salyapongse, G. A. Bragdon, L. L. Shears II, S. C. Watkins, H. D. J. Edington, and T. R. Billiar Impaired wound healing and angiogenesis in eNOS-deficient mice Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1600 - H1608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. SCALIA, G. BOOTH, and D. J. LEFER Vascular endothelial growth factor attenuates leukocyte–endothelium interaction during acute endothelial dysfunction: essential role of endothelium-derived nitric oxide FASEB J, June 1, 1999; 13(9): 1039 - 1046. [Abstract] [Full Text]
|
|
|
|
|
|
H. m. Wu, Y. Yuan, D. C. Zawieja, J. Tinsley, and H. J. Granger Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H535 - H542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB J, January 1, 1999; 13(1): 9 - 22. [Abstract] [Full Text]
|
|
|
|
|
|
B.-Q. Shen, D. Y. Lee, H.-P. Gerber, B. A. Keyt, N. Ferrara, and T. F. Zioncheck Homologous Up-regulation of KDR/Flk-1 Receptor Expression by Vascular Endothelial Growth Factor in Vitro J. Biol. Chem., November 6, 1998; 273(45): 29979 - 29985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hood and H. J. Granger Protein Kinase G Mediates Vascular Endothelial Growth Factor-induced Raf-1 Activation and Proliferation in Human Endothelial Cells J. Biol. Chem., September 4, 1998; 273(36): 23504 - 23508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Gille, J. Kowalski, B. Li, J. LeCouter, B. Moffat, T. F. Zioncheck, N. Pelletier, and N. Ferrara Analysis of Biological Effects and Signaling Properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A REASSESSMENT USING NOVEL RECEPTOR-SPECIFIC VASCULAR ENDOTHELIAL GROWTH FACTOR MUTANTS J. Biol. Chem., January 26, 2001; 276(5): 3222 - 3230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Thuringer, L. Maulon, and C. Frelin Rapid Transactivation of the Vascular Endothelial Growth Factor Receptor KDR/Flk-1 by the Bradykinin B2 Receptor Contributes to Endothelial Nitric-oxide Synthase Activation in Cardiac Capillary Endothelial Cells J. Biol. Chem., January 11, 2002; 277(3): 2028 - 2032. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
